Neuropace Inc Stock (NPCE) Financials Data
*All numbers in millions
| Period End Date | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
| Revenues | 1.22%23.10 | 22.83 | 22.07 | 26.59 | 27.35 |
| Cost Of Revenue | 7.32%3.63 | 3.92 | 4.02 | 6.01 | 6.19 |
| Gross Profit | 2.99%19.47 | 18.91 | 18.05 | 20.58 | 21.17 |
10.39%21.55 | 24.05 | 23.62 | 22.35 | 23.77 | |
| Research and Development | 10.61%6.17 | 6.90 | 7.19 | 7.03 | 6.58 |
| Operating Income/Loss | 59.56%-2.08 | -5.14 | -5.57 | -1.77 | -2.60 |
| Income/Loss From Continuing Operations After Tax | 46.81%-3.30 | -6.20 | - | -2.73 | -3.50 |
| Income/Loss From Discontinued Operations, Net Of Tax | - | - | - | - | - |
46.81%-3.30 | -6.20 | -6.69 | -2.73 | -3.50 | |
| Attributable To Parent | 46.81%-3.30 | -6.20 | -6.69 | -2.73 | -3.50 |
| Basic Average Shares | 0.71%34.35 | 34.10 | 33.72 | 0.22 | 33.13 |
| Diluted Average Shares | 0.71%34.35 | 34.10 | 33.72 | 0.22 | 33.13 |
| Basic Earnings Per Share | 44.44%-0.10 | -0.18 | -0.20 | -0.08 | -0.11 |
| Diluted Earnings Per Share | 44.44%-0.10 | -0.18 | -0.20 | -0.08 | -0.11 |
| Common Stock Dividends | - | - | - | - | - |